Synonym: 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride; THIP hydrochloride
CAS Number: 85118-33-8
Empirical Formula (Hill Notation): C6H8N2O2 · HCl
Molecular Weight: 176.60
EC Number: 285-687-7
MDL Number: MFCD00055180
Linear Formula: C6H8N2O2 · HCl
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts T101-25MG.
| assay |
≥98% (HPLC) |
| color |
white |
| form |
solid |
| InChI |
1S/C6H8N2O2.ClH/c9-6-4-1-2-7-3-5(4)10-8-6;/h7H,1-3H2,(H,8,9);1H |
| InChI key |
ZDZDSZQYRBZPNN-UHFFFAOYSA-N |
| Quality Level |
100  |
| SMILES string |
Cl[H].Oc1noc2CNCCc12 |
| solubility |
ethanol: 0.91 mg/mL |
| |
H2O: 20 mg/mL |
| storage condition |
desiccated |
| Application: |
Gaboxadol hydrochloride has been used in cell migration and invasion assay to assess liver cancer cell migration. |
| Biochem/physiol Actions: |
GABAA receptor agonist. |
| Disclaimer: |
Photosensitive |
| General description: |
Gaboxadol, also referred to as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP), is a GABA site agonist. It has great affinity to the δ subunit of extrasynaptic high-affinity GABAA receptors. Gaboxadol was first developed for the treatment of schizophrenia, epilepsy, primary insomnia and Huntington’s disease. It can easily cross the blood-brain barrier and is rapidly absorbed by the body. |
| Packaging: |
25, 100, 500 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| UNSPSC |
12352100 |